Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fat-soluble vitamins is a combination pharmaceutical product containing vitamins A, D, E, and K, formulated for intravenous administration. This specific intervention is being evaluated by the First Affiliated Hospital of Xi'an Jiaotong University in a Phase 3 clinical trial (NCT04121442) to address deficiencies in very low birth weight (VLBW) infants. The treatment aims to prevent or mitigate common neonatal complications, including bronchopulmonary dysplasia, sepsis, patent ductus arteriosus, and anemia, while supporting neural development. Vitamin A (retinol) is essential for vision and immune function; Vitamin D (cholecalciferol/ergocalciferol) regulates bone metabolism and calcium homeostasis; Vitamin E (alpha-tocopherol) provides antioxidant protection against oxidative stress; and Vitamin K (phytomenadione) is a critical cofactor for blood coagulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fat-soluble vitamins.